Assessment of serum 25-hydroxyvitamin D, insulin-like growth factor 1, malnutrition-inflammation score, and gene expression of VDR and IGFBP-3 in patients with diabetic nephropathy
Background. Diabetic nephropathy (DN) is a major cause of end-stage renal disease globally. Knowledge of the role of deficiency in 25-hydroxyvitamin D (25(OH)D) as well as dysregulation of insulin-like growth factor 1 (IGF-1) levels and increased malnutrition-inflammation score (MIS) in the pathogenesis and progression of DN remains important. Vitamin D receptor (VDR) and insulin-like growth factor-binding protein 3 (IGFBP-3) gene expression is molecular basis that remains incompletely characterized. The purpose of the study was to assess serum 25(OH)D, MIS, and IGF-1 in relation to peripheral blood mononuclear cell mRNA expression of VDR and IGFBP-3 in patients with type 2 diabetes mellitus (T2DM), with and without nephropathy, and to determine their diagnostic performance using receiver operating characteristic analysis. Materials and methods. A cross-sectional case-control study enrolled 160 participants equally distributed into four groups (n = 40 each): group I — healthy controls (HC); group II — T2DM without DN; group III — T2DM with microalbuminuric DN; group IV — T2DM with macroalbuminuric DN. Serum 25(OH)D was measured by enzyme-linked immunosorbent assay; MIS was determined via validated score; serum IGF-1 was quantified by immunoassay. VDR and IGFBP-3 mRNA expression in peripheral blood mononuclear cells was assessed by quantitative real-time polymerase chain reaction using the 2–∆∆Ct method with GAPDH as the reference gene. Additional biochemical parameters including HbA1c, fasting blood glucose, serum creatinine, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio, lipid profile, and complete blood count were determined. Results. Serum 25(OH)D and IGF-1 levels decreased progressively from group I to group IV (p < 0.001), whereas MIS increased significantly (p < 0.001). VDR mRNA expression was significantly downregulated in DN patients (group IV: 0.21 ± 0.04 vs. group I: 1.00 ± 0.06, p < 0.001), exhibiting a strong positive correlation with serum 25(OH)D (r = 0.847, p < 0.001) and eGFR (r = 0.793, p < 0.001). In contrast, IGFBP-3 mRNA increased progressively with DN severity (group IV = 3.87 ± 0.29 vs. group I = 1.00 ± 0.08; p < 0.001) and correlated inversely with serum IGF-1 (r = –0.832, p < 0.001). Receiver operating characteristic analysis showed eGFR as its strongest single discriminator (AUC = 0.891), followed by VDR mRNA (AUC = 0.879), serum 25(OH)D (AUC = 0.871), IGFBP-3 mRNA (AUC = 0.865), MIS (AUC = 0.853). Conclusions. Significant alterations in serum 25(OH)D, MIS, IGF-1, and VDR and IGFBP-3 gene expression characterize diabetic nephropathy and track its severity.
Authors
- Hamzah Hashim Kzar (ORCID: https://orcid.org/0000-0002-6215-3681)
- Rawaa Adday Ali (ORCID: https://orcid.org/0000-0002-2559-703X)
- Abbas Abed Sharhan
- S. H. Ali2 (ORCID: https://orcid.org/0000-0001-6561-9347)
Institutions
- Al-Qasim Green University (IQ)
Publication Details
- Journal
- INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.22141/2224-0721.22.7.2026.1785
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00